Novel treatment for cancer: Immunotherapy trials show promise in curing the disease

In the winter of 2013, Sue Scott, then 36, had already planned her own funeral. Her cervical cancer was spreading fast. Multiple rounds of chemotherapy, radiation and surgery had all failed. Tumours were invading her liver and colon, and squeezing her ureters. Her last chance was to enroll in an experimental trial in which doctors were trying to partially replace patients’ immune systems with T-cells that would specifically attack cancers caused by the human papillomavirus (HPV), a common sexually transmitted infection. Within a few months, her tumours completely disappeared. This…

Read More

Novel device detects bacteria and suggests apt antibiotic

An interdisciplinary team of engineers and pharmaceutical researchers at the University of Alberta has invented a device that can rapidly identify harmful bacteria and can determine whether it is resistant to antibiotics. The device could save precious hours in patient care and public health, and prevent the spread of drug-resistant strains of bacteria. The team’s findings can help in detecting bacteria and measure their susceptibility to antibiotics in small confined volumes. The device was designed to look for and trap different types of bacteria and find out which antibiotics are…

Read More

Novel device lets in three-D imaging of breast with much less radiation

Researchers have located a new device that allows for 3-D molecular breast pics at better resolution than contemporary 2-D scans whilst reducing down the radiation dosages. the new tool known as variable attitude slant hollow collimator or VASH collimator replaces a aspect in current molecular breast imagers. The findings showed that the VASH collimator may also allow existing breast cancer imagers to offer up to 6 times higher contrast of tumours in the breast even as keeping the same or better photograph first-rate. similarly, the device may even gift the…

Read More